20 October 2024

Howe Street Reporter Title

Author: Staff

  • Wellfield Technologies (WFLD.V) CEO posts update, revenue spikes

    Wellfield Technologies (WFLD.V) CEO posts update, revenue spikes

    It’s been held underwater for some time on the back of negative cryptocurrency sentiment, but former Equity.Guru client Wellfield Technologies (WFLD.V) appears to be finally making a run against the tides, with CEO Levy Cohen pointing out a large spike in revenues this quarter (based off unaudited figures) as Wellfield’s new subsidiary Coinmama.com begins to…

  • Corporate America is Cancelling Kanye.

    Corporate America is Cancelling Kanye.

    A particularly unlikeable public figure has metaphorically snatched the mic, yet again. Yes, I’m talking about Kanye West. West is also known as (for my age 50+ readers) “Yeezy”, and for short, “Ye” (a self-proclaimed nickname derived from Jesus). Kanye began using this nickname to position himself as a God of Rap. He has since…

  • All Things Emergency Funds

    All Things Emergency Funds

    I’m thinking of re-cutting bangs and no, this doesn’t mean I’m having a crisis. For whatever reason, the act of cutting the front pieces of your hair shorter than the rest of your hair has become inextricably linked to the notion of emotional catastrophe. You got fired from your job? Bangs. You went through a…

  • Yensanity! Why the Bank of Japan matters!

    Yensanity! Why the Bank of Japan matters!

    Months ago, I warned readers that the Bank of Japan is the most important central bank to be watching. I even did a video explaining why every trader must be watching the Bank of Japan (BoJ). Nobody really cared much about the BoJ since their monetary policy meetings never changed. But things could be changing.…

  • Will Azincourt Energy (AAZ.V) hit it big in the Athabasca Basin?

    Will Azincourt Energy (AAZ.V) hit it big in the Athabasca Basin?

    Azincourt Energy (AAZ.V) is a uranium exploration company with assets in the Athabasca Basin and Peru. The company is currently focusing on their Canadian assets. Azincourt’s most advanced project is East Preston, neighboring some really high-grade uranium deposits such as Nexgen’s Arrow, and Fission’s Triple R. The company controls a >70% interest in the project…

  • When Can I Retire?

    When Can I Retire?

    This week, I accidentally found out that Mario is 41 years old. I guess that’s what the decades of the running, the jumping, and the smashing the bricks with the head does to someone – it ages them. This type of behavior naturally takes its toll… Who’s going to tell him it’s spinal-fusion time? Arguably…

  • Northern Lights (NLR.C) advances projects in Arizona and Nevada

    Northern Lights (NLR.C) advances projects in Arizona and Nevada

    Northern Lights (NLR.C) is a micro-cap (market cap: $650,000) resource developer, advancing two projects With a sub-$1 million market cap, you could be forgiven for thinking that NLR management are dilettantes, the EPA has blacklisted the company and the land packages lack geological interest. But none of those things are true. Northern Lights spends little…

  • NioCorp (NB.T) is developing the next niobium mine!

    NioCorp (NB.T) is developing the next niobium mine!

    If you want to invest in something with a bold geopolitical flavor, then rare earth minerals are the investment for you. When the China trade war headlines were all the markets were talking about way back when, rare earth minerals were always in articles titled something along the lines of, “Possible China trade war weapons”.…

  • “How Millennials Became the Burnout Generation”

    “How Millennials Became the Burnout Generation”

    Shalom again! Since we last spoke, there’s only been two substantial updates to my life. One is that I finally watched Baz Luhrmann’s Elvis (I know, late to the party) and I can’t stop thinking about how the film described the latter half of his life as being like a bird with no place to…

  • Medexus Pharmaceuticals (MDP.TO) Q2 2023 revenue expected to exceed US$27 million

    Medexus Pharmaceuticals (MDP.TO) Q2 2023 revenue expected to exceed US$27 million

    Medexus Pharmaceuticals (MDP.TO) is a specialty pharma company that has been making big moves on the charts. The company is not a biotech company. They do not do research and development, but instead bring over drugs that are already licensed in Western Europe to North America which sees them carve out a nice and profitable…